Pulmonx logo



Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier par...


Add photos to showcase Pulmonx’s culture


Add Pulmonx’s values

Insider experiences

Share your experience of working at Pulmonx

Glendon E. French
President & CEO
Derrick Sung
Chief Financial Officer
Sri Radhakrishnan
Chief Technical Officer
Beran Rose
Chief Commercial Officer
David Lehman
General Counsel
Jérôme Erath
SVP & General Manager, Europe, the Middle East & Africa
Mahtab Fatemi
VP, Regulatory Affairs & Quality Assurance
Marcee Maroney
VP, Marketing
Narinder S. Shargill
VP, Global Medical Affairs
Kelly M. Shriner
VP, Patient Access
Sarah Huber
Vice President, Sales, US

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure